FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Stem Cell Res Ther / Mapping of equine mesenchymal stromal cell surface proteomes...
Stem cell research & therapy2018; 9(1); 288; doi: 10.1186/s13287-018-1041-8

Mapping of equine mesenchymal stromal cell surface proteomes for identification of specific markers using proteomics and gene expression analysis: an in vitro cross-sectional study.

Abstract: Stem cells have great potential for tissue regeneration, but before stem cell populations can be used in the clinic, it is crucial that the stem cells have been definitely characterized by a set of specific markers. Although there have been attempts to identify a set of immunophenotypic markers to characterize equine mesenchymal stromal cells (MSCs), immunophenotyping of equine MSCs is still challenging due to the limited availability of suitable antibodies of high quality and consistent performance across different laboratories. The aim of this study was to evaluate a strategy for mapping the equine MSCs surface proteome by use of biotin-enrichment and mass spectrometry (MS) analysis and mine the proteome for potential equine MSCs surface markers belonging to the cluster of differentiation protein group. Gene expression analysis was used for verification. Equine MSCs derived from bone marrow (BM) (n = 3) and adipose tissue (AT) (n = 3) were expanded to P3 and either used for (1) cell differentiation into mesodermal lineages (chondrogenic and osteogenic), (2) enrichment of the MSCs surface proteins by biotinylation followed by in-gel digest of the isolated proteins and nanoLC-MS/MS analysis to unravel the enriched cell surface proteome, and (3) RNA isolation and quantitative real-time reverse transcriptase PCR analysis of the CD29, CD44, CD90, CD105, CD166, CD34, CD45, and CD79a gene expression. A total of 1239 proteins at 1% FDR were identified by MS analysis of the enriched MSCs surface protein samples. Of these proteins, 939 were identified in all six biological samples. The identified proteins included 19 proteins appointed to the cluster of differentiation classification system as potential cell surface targets. The protein and gene expression pattern was positive for the commonly used positive MSCs markers CD29, CD44, CD90, CD105, and CD166, and lacked the negative MSCs markers CD34, CD45, and CD79a. The findings of this study show that enrichment of the MSCs surface proteome by biotinylation followed by MS analysis is a valuable alternative to immunophenotyping of surface markers, when suitable antibodies are not available. Further, they support gene expression analysis as a valuable control analysis to verify the data.
Get Full Text
Publication Date: 2018-10-25 PubMed ID: 30359315PubMed Central: PMC6202851DOI: 10.1186/s13287-018-1041-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on an innovative approach for identifying immunophenotypic markers to characterize equine mesenchymal stromal cells (MSCs). The method involves mapping the equine MSCs surface proteome using biotin-enrichment, mass spectrometry analysis, and gene expression analysis.

Objective of the Study

  • The primary objective of the researchers was to develop a dependable method for characterizing equine MSCs. This was necessitated by the challenges faced during immunophenotyping due to insufficient high quality and consistent performing antibodies.

Methodology of the Study

  • Equine MSCs were derived from bone marrow and adipose tissue and were taken through different processes such as cell differentiation into mesodermal lineages (osteogenic and chondrogenic).
  • An enrichment process of the MSCs surface proteins was conducted through biotinylation. This was then followed by in-gel digest of the proteins that were isolated and nanoLC-MS/MS analysis to discover the enriched cell surface proteome.
  • Further, RNA isolation was carried out and quantitative real-time reverse transcriptase PCR analysis was conducted for gene expression analysis.

Results of the Study

  • A total of 1239 proteins were identified through the MS analysis of the enriched MSCs surface protein samples. Out of these, 939 proteins were identified in all six biological samples.
  • 19 of these proteins were appointed to the cluster of differentiation classification system as possible cell surface targets.
  • The patterns of protein and gene expressions were positive for commonly used positive MSCs markers such as CD29, CD44, CD90, CD105, and CD166, and negative for MSCs markers such as CD34, CD45, and CD79a.

Conclusion of the Study

  • The study concludes that enrichment of the MSCs surface proteome by biotinylation followed by MS analysis is a dependable alternative to immunophenotyping of surface markers, particularly when suitable antibodies are not available.
  • The study further emphasized that gene expression analysis can serve as a valuable control analysis for validation of data.

Cite This Article

APA
Bundgaard L, Stensballe A, Elbæk KJ, Berg LC. (2018). Mapping of equine mesenchymal stromal cell surface proteomes for identification of specific markers using proteomics and gene expression analysis: an in vitro cross-sectional study. Stem Cell Res Ther, 9(1), 288. https://doi.org/10.1186/s13287-018-1041-8

Publication

Stem cell research & therapy
ISSN: 1757-6512
NlmUniqueID: 101527581
Country: England
Language: English
Volume: 9
Issue: 1
Pages: 288
PII: 288

Researcher Affiliations

Bundgaard, Louise
  • Department of Veterinary Clinical Sciences, University of Copenhagen, Agrovej 8, DK-2630, Taastrup, Denmark. lb@sund.ku.dk.
Stensballe, Allan
  • Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7, 9220, Aalborg Ø, Denmark.
Elbæk, Kirstine Juul
  • Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 7, 9220, Aalborg Ø, Denmark.
Berg, Lise Charlotte
  • Department of Veterinary Clinical Sciences, University of Copenhagen, Agrovej 8, DK-2630, Taastrup, Denmark.

MeSH Terms

  • Animals
  • Biomarkers / metabolism
  • Cell Differentiation
  • Cell Lineage
  • Cell Shape
  • Cross-Sectional Studies
  • Gene Expression Regulation
  • Horses / metabolism
  • Mass Spectrometry
  • Mesenchymal Stem Cells / cytology
  • Proteome / metabolism
  • Proteomics / methods

Conflict of Interest Statement

ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The experimental protocol was approved by the Ethics and Welfare Committee of Department of Veterinary Clinical Sciences, University of Copenhagen, and all procedures were carried out according to the Danish Act on animal experiments. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

This article includes 34 references
  1. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects.. Arthroscopy 2011 Nov;27(11):1552-61.
    doi: 10.1016/j.arthro.2011.06.002pubmed: 21862278google scholar: lookup
  2. Ferris DJ, Frisbie DD, Kisiday JD, McIlwraith CW, Hague BA, Major MD, Schneider RK, Zubrod CJ, Kawcak CE, Goodrich LR. Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury.. Vet Surg 2014 Mar;43(3):255-65.
    doi: 10.1111/j.1532-950X.2014.12100.xpubmed: 24433318google scholar: lookup
  3. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.. Cytotherapy 2006;8(4):315-7.
    doi: 10.1080/14653240600855905pubmed: 16923606google scholar: lookup
  4. Guest DJ, Ousey JC, Smith MR. Defining the expression of marker genes in equine mesenchymal stromal cells.. Stem Cells Cloning 2008;1:1-9.
    pmc: PMC3781685pubmed: 24198500doi: 10.2147/sccaa.s3824google scholar: lookup
  5. Radcliffe CH, Flaminio MJ, Fortier LA. Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.. Stem Cells Dev 2010 Feb;19(2):269-82.
    doi: 10.1089/scd.2009.0091pmc: PMC3138180pubmed: 19604071google scholar: lookup
  6. De Schauwer C, Meyer E, Van de Walle GR, Van Soom A. Markers of stemness in equine mesenchymal stem cells: a plea for uniformity.. Theriogenology 2011 May;75(8):1431-43.
    doi: 10.1016/j.theriogenology.2010.11.008pubmed: 21196039google scholar: lookup
  7. De Schauwer C, Piepers S, Van de Walle GR, Demeyere K, Hoogewijs MK, Govaere JL, Braeckmans K, Van Soom A, Meyer E. In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.. Cytometry A 2012 Apr;81(4):312-23.
    doi: 10.1002/cyto.a.22026pubmed: 22411893google scholar: lookup
  8. Ibrahim S, Saunders K, Kydd JH, Lunn DP, Steinbach F. Screening of anti-human leukocyte monoclonal antibodies for reactivity with equine leukocytes.. Vet Immunol Immunopathol 2007 Sep 15;119(1-2):63-80.
    doi: 10.1016/j.vetimm.2007.06.034pubmed: 17707518google scholar: lookup
  9. Riis S, Stensballe A, Emmersen J, Pennisi CP, Birkelund S, Zachar V, Fink T. Mass spectrometry analysis of adipose-derived stem cells reveals a significant effect of hypoxia on pathways regulating extracellular matrix.. Stem Cell Res Ther 2016 Apr 14;7(1):52.
    doi: 10.1186/s13287-016-0310-7pmc: PMC4831147pubmed: 27075204google scholar: lookup
  10. Belleannee C, Belghazi M, Labas V, Teixeira-Gomes AP, Gatti JL, Dacheux JL, Dacheux F. Purification and identification of sperm surface proteins and changes during epididymal maturation.. Proteomics 2011 May;11(10):1952-64.
    doi: 10.1002/pmic.201000662pubmed: 21472858google scholar: lookup
  11. Kasvandik S, Sillaste G, Velthut-Meikas A, Mikelsaar AV, Hallap T, Padrik P, Tenson T, Jaakma Ü, Kõks S, Salumets A. Bovine sperm plasma membrane proteomics through biotinylation and subcellular enrichment.. Proteomics 2015 Jun;15(11):1906-20.
    doi: 10.1002/pmic.201400297pubmed: 25603787google scholar: lookup
  12. Niehage C, Karbanová J, Steenblock C, Corbeil D, Hoflack B. Cell Surface Proteome of Dental Pulp Stem Cells Identified by Label-Free Mass Spectrometry.. PLoS One 2016;11(8):e0159824.
    doi: 10.1371/journal.pone.0159824pmc: PMC4973913pubmed: 27490675google scholar: lookup
  13. Niehage C, Steenblock C, Pursche T, Bornhäuser M, Corbeil D, Hoflack B. The cell surface proteome of human mesenchymal stromal cells.. PLoS One 2011;6(5):e20399.
    doi: 10.1371/journal.pone.0020399pmc: PMC3102717pubmed: 21637820google scholar: lookup
  14. Lee SK, Kim JH, Kim SS, Kang T, Park NH, Kwon KH, Lee SS, Lee ZW, Suh-Kim Hy, Cho K, Yun SY, Han JY, Yoo JS, An HJ, Park YM. Profiling and semiquantitative analysis of the cell surface proteome in human mesenchymal stem cells.. Anal Bioanal Chem 2013 Jun;405(16):5501-17.
    doi: 10.1007/s00216-013-6969-zpubmed: 23657447google scholar: lookup
  15. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.. Mol Cell Proteomics 2014 Sep;13(9):2513-26.
    doi: 10.1074/mcp.M113.031591pmc: PMC4159666pubmed: 24942700google scholar: lookup
  16. Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, Jensen LJ, von Mering C. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.. Nucleic Acids Res 2017 Jan 4;45(D1):D362-D368.
    doi: 10.1093/nar/gkw937pmc: PMC5210637pubmed: 27924014google scholar: lookup
  17. Vizcaíno JA, Csordas A, Del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol Y, Reisinger F, Ternent T, Xu QW, Wang R, Hermjakob H. 2016 update of the PRIDE database and its related tools.. Nucleic Acids Res 2016 Dec 15;44(22):11033.
    doi: 10.1093/nar/gkw880pmc: PMC5159556pubmed: 27683222google scholar: lookup
  18. Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.. Cancer Res 2004 Aug 1;64(15):5245-50.
    doi: 10.1158/0008-5472.CAN-04-0496pubmed: 15289330google scholar: lookup
  19. Maia L, de Moraes CN, Dias MC, Martinez JB, Caballol AO, Testoni G, de Queiroz CM, Peña RD, Landim-Alvarenga FC, de Oliveira E. A proteomic study of mesenchymal stem cells from equine umbilical cord.. Theriogenology 2017 Sep 15;100:8-15.
    doi: 10.1016/j.theriogenology.2017.05.015pubmed: 28708537google scholar: lookup
  20. Dhar M, Neilsen N, Beatty K, Eaker S, Adair H, Geiser D. Equine peripheral blood-derived mesenchymal stem cells: isolation, identification, trilineage differentiation and effect of hyperbaric oxygen treatment.. Equine Vet J 2012 Sep;44(5):600-5.
    doi: 10.1111/j.2042-3306.2011.00536.xpubmed: 22333000google scholar: lookup
  21. Ranera B, Lyahyai J, Romero A, Vázquez FJ, Remacha AR, Bernal ML, Zaragoza P, Rodellar C, Martín-Burriel I. Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue.. Vet Immunol Immunopathol 2011 Nov 15;144(1-2):147-54.
    doi: 10.1016/j.vetimm.2011.06.033pubmed: 21782255google scholar: lookup
  22. Paebst F, Piehler D, Brehm W, Heller S, Schroeck C, Tárnok A, Burk J. Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition.. Cytometry A 2014 Aug;85(8):678-87.
    doi: 10.1002/cyto.a.22491pubmed: 24894974google scholar: lookup
  23. Bundgaard L, Jacobsen S, Sørensen MA, Sun Z, Deutsch EW, Moritz RL, Bendixen E. The Equine PeptideAtlas: a resource for developing proteomics-based veterinary research.. Proteomics 2014 Mar;14(6):763-73.
    doi: 10.1002/pmic.201300398pmc: PMC4340707pubmed: 24436130google scholar: lookup
  24. Hesselager MO, Codrea MC, Sun Z, Deutsch EW, Bennike TB, Stensballe A, Bundgaard L, Moritz RL, Bendixen E. The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine.. Proteomics 2016 Feb;16(4):634-44.
    doi: 10.1002/pmic.201500195pmc: PMC4786621pubmed: 26699206google scholar: lookup
  25. Rider DA, Nalathamby T, Nurcombe V, Cool SM. Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells.. J Mol Histol 2007 Oct;38(5):449-58.
    doi: 10.1007/s10735-007-9128-zpubmed: 17694277google scholar: lookup
  26. Griesche N, Luttmann W, Luttmann A, Stammermann T, Geiger H, Baer PC. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells.. Cells Tissues Organs 2010;192(2):106-15.
    doi: 10.1159/000289586pubmed: 20185896google scholar: lookup
  27. Garcia J, Mennan C, McCarthy HS, Roberts S, Richardson JB, Wright KT. Chondrogenic Potency Analyses of Donor-Matched Chondrocytes and Mesenchymal Stem Cells Derived from Bone Marrow, Infrapatellar Fat Pad, and Subcutaneous Fat.. Stem Cells Int 2016;2016:6969726.
    doi: 10.1155/2016/6969726pmc: PMC5066011pubmed: 27781068google scholar: lookup
  28. Lee HJ, Choi BH, Min BH, Park SR. Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro.. Arthritis Rheum 2009 Aug;60(8):2325-32.
    doi: 10.1002/art.24786pubmed: 19644865google scholar: lookup
  29. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells.. J Cell Physiol 2001 Oct;189(1):54-63.
    doi: 10.1002/jcp.1138pubmed: 11573204google scholar: lookup
  30. Irioda AC, Cassilha R, Zocche L, Francisco JC, Cunha RC, Ferreira PE, Guarita-Souza LC, Ferreira RJ, Mogharbel BF, Garikipati VN, Souza D, Beltrame MP, de Carvalho KA. Human Adipose-Derived Mesenchymal Stem Cells Cryopreservation and Thawing Decrease α4-Integrin Expression.. Stem Cells Int 2016;2016:2562718.
    doi: 10.1155/2016/2562718pmc: PMC4770156pubmed: 26981129google scholar: lookup
  31. Blasi A, Martino C, Balducci L, Saldarelli M, Soleti A, Navone SE, Canzi L, Cristini S, Invernici G, Parati EA, Alessandri G. Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential.. Vasc Cell 2011 Feb 8;3(1):5.
    doi: 10.1186/2045-824X-3-5pmc: PMC3044104pubmed: 21349162google scholar: lookup
  32. Giesert C, Marxer A, Sutherland DR, Schuh AC, Kanz L, Buhring HJ. Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsets.. Ann N Y Acad Sci 2003 May;996:227-30.
    doi: 10.1111/j.1749-6632.2003.tb03250.xpubmed: 12799300google scholar: lookup
  33. Zhou S, Cecere R, Philip A. CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.. Oncotarget 2017 Nov 10;8(56):95632-95647.
    pmc: PMC5707049pubmed: 29221155doi: 10.18632/oncotarget.21067google scholar: lookup
  34. Christy BA, Herzig MC, Montgomery RK, Delavan C, Bynum JA, Reddoch KM, Cap AP. Procoagulant activity of human mesenchymal stem cells.. J Trauma Acute Care Surg 2017 Jul;83(1 Suppl 1):S164-S169.
    doi: 10.1097/TA.0000000000001485pubmed: 28628602google scholar: lookup

Citations

This article has been cited 6 times.
  1. Petrova V, Vachkova E. Outlook of Adipose-Derived Stem Cells: Challenges to Their Clinical Application in Horses.. Vet Sci 2023 May 12;10(5).
    doi: 10.3390/vetsci10050348pubmed: 37235430google scholar: lookup
  2. Bagge J, Berg LC, Janes J, MacLeod JN. Donor age effects on in vitro chondrogenic and osteogenic differentiation performance of equine bone marrow- and adipose tissue-derived mesenchymal stromal cells.. BMC Vet Res 2022 Nov 3;18(1):388.
    doi: 10.1186/s12917-022-03475-2pubmed: 36329434google scholar: lookup
  3. Akpinar G, Yoneten KK, Kasap M, Karaoz E. Search for Novel Plasma Membrane Proteins as Potential Biomarkers in Human Mesenchymal Stem Cells Derived from Dental Pulp, Adipose Tissue, Bone Marrow, and Hair Follicle.. J Membr Biol 2021 Aug;254(4):409-422.
    doi: 10.1007/s00232-021-00190-1pubmed: 34230997google scholar: lookup
  4. Bagge J, MacLeod JN, Berg LC. Cellular Proliferation of Equine Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells Decline With Increasing Donor Age.. Front Vet Sci 2020;7:602403.
    doi: 10.3389/fvets.2020.602403pubmed: 33363241google scholar: lookup
  5. Mançanares ACF, Cabezas J, Manríquez J, de Oliveira VC, Wong Alvaro YS, Rojas D, Navarrete Aguirre F, Rodriguez-Alvarez L, Castro FO. Edition of Prostaglandin E2 Receptors EP2 and EP4 by CRISPR/Cas9 Technology in Equine Adipose Mesenchymal Stem Cells.. Animals (Basel) 2020 Jun 23;10(6).
    doi: 10.3390/ani10061078pubmed: 32585798google scholar: lookup
  6. Bundgaard L, Stensballe A, Elbæk KJ, Berg LC. Mass spectrometric analysis of the in vitro secretome from equine bone marrow-derived mesenchymal stromal cells to assess the effect of chondrogenic differentiation on response to interleukin-1β treatment.. Stem Cell Res Ther 2020 May 20;11(1):187.
    doi: 10.1186/s13287-020-01706-7pubmed: 32434555google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.